Nicolai J Wewer Albrechtsen
Overview
Explore the profile of Nicolai J Wewer Albrechtsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
2515
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hansen L, Gasbjerg L, Bronden A, Dalsgaard N, Bahne E, Stensen S, et al.
Eur J Endocrinol
. 2024 Jul;
191(2):192-203.
PMID: 39049802
Aims: Although metformin is widely used for treatment of type 2 diabetes (T2D), its glucose-lowering mechanism remains unclear. Using the glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) antagonist exendin(9-39)NH2, we tested...
12.
Kjeldsen S, Richter M, Jensen N, Nilsson M, Heinz N, Nybing J, et al.
Diabetes
. 2024 Jul;
73(10):1716-1727.
PMID: 38976454
Article Highlights:
13.
Kaag Rasmussen M, Mollgard K, Bork P, Weikop P, Esmail T, Drici L, et al.
Science
. 2024 Jul;
385(6704):80-86.
PMID: 38963846
Classical migraine patients experience aura, which is transient neurological deficits associated with cortical spreading depression (CSD), preceding headache attacks. It is not currently understood how a pathological event in cortex...
14.
Zhang D, Zhu J, Wewer Albrechtsen N, Rayner C, Saffery R, Zhang H, et al.
Diabetes Obes Metab
. 2024 Jul;
26(9):3926-3934.
PMID: 38957925
Aim: To evaluate insulin and glucagon sensitivity in Han Chinese women with and without gestational diabetes mellitus (GDM). Methods: In total, 81 women with GDM and 81 age-matched healthy controls...
15.
London A, Richter M, Sjoberg K, Wewer Albrechtsen N, Povazan M, Drici L, et al.
Am J Clin Nutr
. 2024 Jun;
120(2):283-293.
PMID: 38914224
Background: Intrahepatic triacylglycerol (liver TG) content is associated with hepatic insulin resistance and dyslipidemia. Liver TG content can be modulated within days under hypocaloric conditions. Objectives: We hypothesized that 4...
16.
Mygind K, Nikodemus D, Gnosa S, Kweder R, Wewer Albrechtsen N, Kveiborg M, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892056
Desmoplasia is a common feature of aggressive cancers, driven by a complex interplay of protein production and degradation. Basigin is a type 1 integral membrane receptor secreted in exosomes or...
17.
Nygaard U, Bach Nielsen A, Dungu K, Drici L, Holm M, Ottenheijm M, et al.
Commun Biol
. 2024 Jun;
7(1):688.
PMID: 38839859
Multisystem inflammatory syndrome in children (MIS-C) is a severe disease that emerged during the COVID-19 pandemic. Although recognized as an immune-mediated condition, the pathogenesis remains unresolved. Furthermore, the absence of...
18.
Kliim-Hansen V, Gether I, Juel C, Ellegaard A, Pedersen M, Hartmann B, et al.
Peptides
. 2024 May;
179:171242.
PMID: 38782050
Oxytocin has been proposed to possess glucose-stabilizing effects through the release of insulin and glucagon from the pancreas. Also, exogenous oxytocin has been shown to stimulate extrapancreatic glucagon secretion in...
19.
Winther-Sorensen M, Garcia S, Bartholdy A, Ottenheijm M, Banasik K, Brunak S, et al.
Diabetologia
. 2024 May;
67(8):1602-1615.
PMID: 38705923
Aims/hypotheses: Glucagon and glucagon-like peptide-1 (GLP-1) are derived from the same precursor; proglucagon, and dual agonists of their receptors are currently being explored for the treatment of obesity and metabolic...
20.
Richter M, Kemp I, Heeboll S, Winther-Sorensen M, Kjeldsen S, Jensen N, et al.
Metabolism
. 2024 Apr;
156:155915.
PMID: 38631460
Introduction: Glucagon receptor agonism is currently explored for the treatment of obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). The metabolic effects of glucagon receptor agonism may in part be...